CVT313 treatment decreased cell number (estimated by total cellular area) in Irbp-Cyclin D1, p18Ink4c -/- and Irbp-Cyclin D1, p53 -/- tumor cells in 8-well chamber slides [Figure 6D, upper panel]. This evidence concerns the gene TP53 and neoplasm.